Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Olaparib
Trade Name Lynparza
Synonyms AZD2281|KU-0059436
Drug Descriptions

Lynparza (olaparib) binds to and inhibits PARP, resulting in inhibition of DNA repair and lethality in homologous-recombination deficient cells, and may be a sensitizing agent for chemotherapy and radiotherapy (PMID: 25028150, PMID: 24225019). Lynparza (olaparib) is FDA approved for treatment of ERBB2 (HER2)-negative breast cancer with deleterious or suspected deleterious germline BRCA mutations, ovarian cancer with deleterious or suspected deleterious germline BRCA mutations and received 3 or more prior therapies, metastatic pancreatic adenocarcinoma with deleterious or suspected deleterious germline BRCA mutations as a maintenance therapy, metastatic castration-resistant prostate cancer with deleterious or suspected deleterious germline or somatic homologous recombination repair gene mutations who progressed following enzalutamide or abiraterone, as a maintenance therapy in recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer and in epithelial ovarian, fallopian tube or primary peritoneal cancer with deleterious or suspected deleterious germline or somatic BRCA mutation, and in combination with Avastin (bevacizumab) as maintenance therapy in HDR defective epithelial ovarian, fallopian tube or primary peritoneal cancer as defined by deleterious or suspected deleterious BRCA mutation, and/or genomic instability (FDA.gov).

DrugClasses PARP Inhibitor (Pan) 23
CAS Registry Number 763113-22-0
NCIT ID C71721

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Abemaciclib + Olaparib Abemaciclib Olaparib 0 1
Abiraterone + Olaparib Abiraterone Olaparib 0 1
Abiraterone + Olaparib + Prednisone Abiraterone Olaparib Prednisone 0 2
Adavosertib + Olaparib Adavosertib Olaparib 0 4
AGI-5198 + Olaparib AGI-5198 Olaparib 1 0
Alpelisib + Olaparib Alpelisib Olaparib 0 2
AsiDNA + Olaparib AsiDNA Olaparib 0 0
Atezolizumab + Olaparib Atezolizumab Olaparib 0 1
AZ31 + Olaparib AZ31 Olaparib 0 0
AZD6482 + Olaparib AZD6482 Olaparib 1 0
AZD7648 + Olaparib AZD7648 Olaparib 3 1
Bemcentinib + Olaparib Bemcentinib Olaparib 0 0
Bendamustine + Olaparib Bendamustine Olaparib 1 0
Berzosertib + Olaparib Berzosertib Olaparib 0 0
Bevacizumab + Carboplatin + Olaparib + Paclitaxel + Pembrolizumab Bevacizumab Carboplatin Olaparib Paclitaxel Pembrolizumab 0 1
Bevacizumab + Carboplatin + Olaparib + Pembrolizumab Bevacizumab Carboplatin Olaparib Pembrolizumab 0 0
Bevacizumab + Cisplatin + Olaparib + Paclitaxel Bevacizumab Cisplatin Olaparib Paclitaxel 0 1
Bevacizumab + Durvalumab + Olaparib Bevacizumab Durvalumab Olaparib 0 2
Bevacizumab + Olaparib Bevacizumab Olaparib 0 1
Bevacizumab + Olaparib + Paclitaxel + Pembrolizumab Bevacizumab Olaparib Paclitaxel Pembrolizumab 0 0
BPTES + Olaparib BPTES Olaparib 1 0
Buparlisib + Olaparib Buparlisib Olaparib 3 1
Camptothecin + Olaparib Camptothecin Olaparib 0 0
Capivasertib + Olaparib Capivasertib Olaparib 0 2
Carboplatin + Durvalumab + Etoposide + Olaparib Carboplatin Durvalumab Etoposide Olaparib 0 1
Carboplatin + Durvalumab + Olaparib + Paclitaxel Carboplatin Durvalumab Olaparib Paclitaxel 0 1
Carboplatin + Gemcitabine + Olaparib + Pembrolizumab Carboplatin Gemcitabine Olaparib Pembrolizumab 0 1
Carboplatin + Olaparib Carboplatin Olaparib 0 0
Carboplatin + Olaparib + Paclitaxel Carboplatin Olaparib Paclitaxel 0 1
Carboplatin + Olaparib + Paclitaxel + Pembrolizumab Carboplatin Olaparib Paclitaxel Pembrolizumab 0 1
Carboplatin + Olaparib + Pembrolizumab Carboplatin Olaparib Pembrolizumab 0 1
CCT241533 + Olaparib CCT241533 Olaparib 0 0
Cediranib + Durvalumab + Olaparib Cediranib Durvalumab Olaparib 0 1
Cediranib + Olaparib Cediranib Olaparib 2 14
Cediranib + Olaparib + Triapine Cediranib Olaparib Triapine 0 0
Ceralasertib + Olaparib Ceralasertib Olaparib 1 10
Cetuximab + Olaparib Cetuximab Olaparib 0 1
CHIR99021 + Olaparib CHIR99021 Olaparib 0 0
Cisplatin + Olaparib Cisplatin Olaparib 0 0
Copanlisib + Durvalumab + Olaparib Copanlisib Durvalumab Olaparib 0 1
CYH33 + Olaparib CYH33 Olaparib 0 1
CYT01B + Olaparib CYT01B Olaparib 0 0
Daunorubicin + Olaparib Daunorubicin Olaparib 2 0
Dinaciclib + Olaparib Dinaciclib Olaparib 0 0
Dubermatinib + Olaparib Dubermatinib Olaparib 0 0
Durvalumab + Fulvestrant + Olaparib Durvalumab Fulvestrant Olaparib 0 1
Durvalumab + Olaparib Durvalumab Olaparib 1 17
Durvalumab + Olaparib + Tremelimumab Durvalumab Olaparib Tremelimumab 0 2
Entinostat + Olaparib Entinostat Olaparib 0 1
Everolimus + Olaparib Everolimus Olaparib 0 0
Fludarabine + Olaparib Fludarabine Olaparib 1 0
Fulvestrant + Olaparib + Palbociclib Fulvestrant Olaparib Palbociclib 0 1
GSK2830371 + Olaparib GSK2830371 Olaparib 0 0
GSK2830371 + Olaparib + Radiotherapy GSK2830371 Olaparib Radiotherapy 0 0
Infigratinib + Olaparib Infigratinib Olaparib 0 0
Irinotecan + Olaparib Irinotecan Olaparib 0 1
KU-0063794 + Olaparib KU-0063794 Olaparib 0 0
lutetium Lu 177 dotatate + Olaparib Olaparib lutetium Lu 177 dotatate 0 1
LY2090314 + Olaparib LY2090314 Olaparib 0 0
MK-8776 + Olaparib MK-8776 Olaparib 0 0
NLG207 + Olaparib NLG207 Olaparib 0 2
Olaparib Olaparib 56 84
Olaparib + Onalespib Olaparib Onalespib 0 1
Olaparib + Paclitaxel Olaparib Paclitaxel 2 0
Olaparib + Paclitaxel + Pembrolizumab Olaparib Paclitaxel Pembrolizumab 0 1
Olaparib + Pamiparib + Temozolomide Olaparib Pamiparib Temozolomide 0 1
Olaparib + Pembrolizumab Olaparib Pembrolizumab 0 17
Olaparib + PLX2853 Olaparib PLX2853 0 1
Olaparib + Prexasertib Olaparib Prexasertib 0 1
Olaparib + Radiotherapy Olaparib Radiotherapy 0 0
Olaparib + Ramucirumab Olaparib Ramucirumab 0 1
Olaparib + RP-3500 Olaparib RP-3500 0 1
Olaparib + Sapacitabine Olaparib Sapacitabine 0 1
Olaparib + Selumetinib Olaparib Selumetinib 0 1
Olaparib + SN-38 Olaparib SN-38 0 0
Olaparib + SN-38 + Temozolomide Olaparib SN-38 Temozolomide 0 0
Olaparib + SR-4835 Olaparib SR-4835 0 0
Olaparib + Telaglenastat Olaparib Telaglenastat 1 0
Olaparib + Temozolomide Olaparib Temozolomide 0 5
Olaparib + Testosterone Enanthate Olaparib Testosterone Enanthate 0 1
Olaparib + THZ1 Olaparib THZ1 0 0
Olaparib + Trabectedin Olaparib Trabectedin 0 3
Olaparib + Trametinib Olaparib Trametinib 0 0
Olaparib + Trametinib + unspecified PD-L1 antibody Olaparib Trametinib unspecified PD-L1 antibody 0 0
Olaparib + Trastuzumab Olaparib Trastuzumab 0 1
Olaparib + Trastuzumab deruxtecan Olaparib Trastuzumab deruxtecan 0 1
Olaparib + Tremelimumab Olaparib Tremelimumab 0 2
Olaparib + Triapine Olaparib Triapine 0 0
Olaparib + unspecified PD-L1 antibody Olaparib unspecified PD-L1 antibody 0 0
Olaparib + USP7-797 Olaparib USP7-797 0 0
Olaparib + Valproic acid Olaparib Valproic acid 1 0
Olaparib + VE-821 Olaparib VE-821 0 0
Olaparib + Vistusertib Olaparib Vistusertib 0 1
Olaparib + Vorinostat Olaparib Vorinostat 0 1
Olaparib + YU238259 Olaparib YU238259 0 0


Additional content available in CKB BOOST